Erythromycin lactobionate
08-008620
Phase 1 small_molecule completed
Quick answer
Erythromycin lactobionate for Diabetes Mellitus, Type 1 is a Phase 1 program (small_molecule) at ADIAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADIAL PHARMACEUTICALS, INC.
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed